Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Merz Group is a global, family-owned healthcare company headquartered in Frankfurt, Germany, with a history spanning over 115 years. The company is organized into three main business units: Merz Aesthetics, Merz Therapeutics, and Merz Consumer Care. Merz Aesthetics is a leading global provider in the medical aesthetics market, featuring a portfolio that includes the botulinum neurotoxin Xeomin, the Radiesse regenerative biostimulator, and the Ultherapy skin-lifting device. Merz Therapeutics focuses on specialized neurological conditions, such as spasticity and movement disorders, as well as liver diseases. The group maintains a strong commitment to research and development, particularly in the field of botulinum neurotoxins and innovative aesthetic treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Merz Group.